Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Dalvance® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth. Dalvance is the first single-dose option administered as a 30-minute intravenous (IV) infusion for… Read More »

Frontline worker hospitalized with COVID-19 has almost $1 million in medical bills

Loading the player… A woman who worked on the frontlines of medicine helping coronavirus patients has been hit with nearly $ 1 million in medical bills after recovering from a severe bout of COVID-19.  Shenita Russie, 42, a mobile respiratory therapist from Little Rock, Arkansas, caught the virus while working in Boston at the pandemic’s… Read More »